CESSATECH
CESSATECH
Industry:
Medical Pharmaceutical
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.cessatech.com
Status:
Active
Contact:
45 9387 2309
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager WordPress Font Awesome Sitelinks Search Box Organization Schema Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
ATGC
ATGC engages in the research and development of drugs.
Official Site Inspections
http://www.cessatech.com
- Host name: linux301.unoeuro.com
- IP address: 93.191.156.191
- Location: Langeskov Denmark
- Latitude: 55.3565
- Longitude: 10.5845
- Timezone: Europe/Copenhagen
- Postal: 5550
More informations about "Cessatech"
About - Cessatech
Cessatech Colored Cessatech’s business model offers unique, scalable economic value creation by identifying and developing drugs with a short time to market and risk-reduced profile. The …See details»
Cessatech - Crunchbase Company Profile & Funding
Organization. Cessatech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Cessatech is a pharmaceutical firm that …See details»
Cessatech A/S (NGM: CESSA) Company Profile & Overview - Stock …
Nov 15, 2024 Cessatech A/S engages in identifying and developing drugs for the treatment of medical unmet need in children in Denmark. The company’s lead product is CT001, an …See details»
Third Quarter Report Q3-2024 - cessatech.com
The Board of Directors and CEO of Cessatech hereby publish the third quarter report of 2024. In this interim report, the following definitions apply, unless stated otherwise: The “!ompany” or …See details»
Cessatech A/S - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cessatech A/S with its drug pipeline, therapeutic area, technology platform, 7 clinical trials, 1 news, Disease Domain:Nervous System Diseases, Technology Platform:Small …See details»
Cessatech Company Profile: Overview and Full News Analysis
Cessatech has been presenting new data on paediatric pain relief, favoring their lead candidate, CT001, at the PAGE conference in Rome. They have announced superior simulated pain …See details»
Third Quarter Report Q3-2024 - Cessatech - Cision News
Nov 13, 2024 For more information about Cessatech, please contact: Jes Trygved, CEO Phone: +45 9387 2309 E-mail: [email protected] www.cessatech.com. About Cessatech …See details»
Cessatech - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 12, 2024: Post-IPO Debt - …See details»
Cessatech - Contacts, Employees, Board Members, Advisors
Organization. Cessatech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. Cessatech has 1 …See details»
Proveca acquires global rights to Cessatech’s CT001 sufentanil ...
Aug 26, 2024 Cessatech and pediatric medicines specialist Proveca have announced a deal that gives Proveca global commercialization rights to Cessatech’s CT001 sufentanil / ketamine …See details»
Cessatech A/S - Annual Report 2021
CESSATECH - ANNUAL REPORT - 2021 1. COMPANY INFORMATION & MANAGEMENT REVIEW 2 2. CESSATECH 4 2.1 Executive summary 4 2.2 Business model and strategy 7 3. …See details»
Cessatech A/S (CESSA.CO) - Yahoo Finance
Find the latest Cessatech A/S (CESSA.CO) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
CESSA Stock Price Quote | Morningstar
Nov 19, 2024 Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute …See details»
Cessatech and Proveca announce world-wide excluding US …
Oct 4, 2024 Cessatech A/S is a Danish pharmaceutical company committed to developing and commercializing evidence-based and innovative medicines for children for the treatment of …See details»
Cessatech - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Cessatech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Monthly Visits 4,723. Monthly Visits Growth 56.18%. …See details»
Cessatech A/S (CESSA) Stock Price Today - WSJ - The Wall Street …
View the latest Cessatech A/S (CESSA) stock price, news, historical charts, analyst ratings and financial information from WSJ.See details»
News, Press, Facts & Events - Cessatech
26. August, 2024. Cessatech and Proveca announce world-wide excluding US commercial partnership for CT001. Cessatech and Proveca enter an exclusive agreement for the …See details»
Cessatech AS (CESSA) - TE CESSA - Investing.com Canada
Cessatech A/S engages in identifying and developing drugs for the treatment of medical unmet need in children in Denmark. The company’s lead product is CT001, an analgesic nasal spray …See details»
Cessatech A/S (Cessatech A/S) - 药物管线_专利_临床试验_投融营 …
了解Cessatech A/S (Cessatech A/S)公司的药物管线，治疗领域，技术平台，以及它的7项临床试验, 1篇新闻，疾病领域:神经系统疾病，技术平台:未知，自体CAR-T，小分子化药，化学药， …See details»